Chronic

Virgin Pulse Adds New Partners & Expanded Offerings to Homebase for Health's Curated Ecosystem to Support Key Health and Wellbeing Needs

Retrieved on: 
Thursday, October 13, 2022

PROVIDENCE, R.I., Oct. 13, 2022 /PRNewswire/ -- Virgin Pulse, the leading global digital-first health and wellbeing company, today announced the addition of five new or expanded partners to its curated ecosystem, providing more support in areas of growing importance for clients and members to drive better outcomes and manage costs. These include surgical centers of excellence, virtual care for chronic conditions, digestive health support, and resources for chronic condition prevention. Additionally, new workforce resilience offerings have been added to its VP+ partner bundle program.

Key Points: 
  • These include surgical centers of excellence, virtual care for chronic conditions, digestive health support, and resources for chronic condition prevention.
  • The following five partners are joining the Virgin Pulse partner ecosystem or expanding their offerings:
    "Our partner resources are an important aspect of our health and wellbeing offerings.
  • Virgin Pulse's partner ecosystem helps companies close gaps in care across more than 20 health and wellbeing categories while addressing the most common and costly health concerns.
  • Yes Health helps people take charge of their health and have fun doing it by developing healthy habits that last a lifetime.

Gen.G Mobil 1 Racing Goes "Full Throttle" into Rocket League Esports with Launch of Two Professional Teams

Retrieved on: 
Thursday, September 29, 2022

Global esports organization Gen.G and the worlds leading synthetic motor oil Mobil 1 today announced a joint, first-of-its-kind Rocket League program: Gen.G Mobil 1 Racing.

Key Points: 
  • Global esports organization Gen.G and the worlds leading synthetic motor oil Mobil 1 today announced a joint, first-of-its-kind Rocket League program: Gen.G Mobil 1 Racing.
  • Elevating its existing relationship with Rocket League, Mobil 1 is expanding its partnership with Gen.G to create two Rocket League teams - one mens and one womens.
  • Weve been looking to get into Rocket League since the very start of Gen.Gs entry into North America.
  • The two will also attend live racing and esports events to meet the Gen.G Mobil 1 Racing community and fans.

Gen.G Mobil 1 Racing Goes "Full Throttle" into Rocket League Esports with Launch of Two Professional Teams

Retrieved on: 
Wednesday, September 28, 2022

LOS ANGELES, Sept. 28, 2022 /PRNewswire/ -- Global esports organization Gen.G and the world's leading synthetic motor oil Mobil 1 today announced a joint, first-of-its-kind Rocket League program: Gen.G Mobil 1 Racing. Elevating its existing relationship with Rocket League, Mobil 1 is expanding its partnership with Gen.G to create two Rocket League teams - one men's and one women's. In addition to the competitive teams, two Rocket League content creators will join the program to elevate the experience for fans on and off the field.

Key Points: 
  • Elevating its existing relationship with Rocket League, Mobil 1 is expanding its partnership with Gen.G to create two Rocket League teams - one men's and one women's.
  • The men's competitive team will compete under "Gen.G Mobil 1 Racing" in the 2022-2023 North American Rocket League Championship Series (NA RLCS), where Mobil 1 has been a sponsor since 2018.
  • "We've been looking to get into Rocket League since the very start of Gen.G's entry into North America.
  • The two will also attend live racing and esports events to meet the Gen.G Mobil 1 Racing community and fans.

The First Diagnostic Test for Long COVID Will Formally Launch in Europe in September

Retrieved on: 
Wednesday, August 31, 2022

The first diagnostic designed to identify patients with long COVID has received CE-IVD marking in Europe.

Key Points: 
  • The first diagnostic designed to identify patients with long COVID has received CE-IVD marking in Europe.
  • The simple blood test can help to objectively diagnose patients suffering from Post-Acute Sequelae of COVID-19 (PASC), commonly known as long COVID.
  • Developed by IncellDx, the test will be available to prescribers and patients in September through one of the worlds largest providers of diagnostic services.
  • The company launched the Chronic COVID Treatment Center to apply precision medicine approaches to evaluate, characterize and more effectively address chronic COVID.

Arisha Announces Release of Project 848 with Suge Knight

Retrieved on: 
Thursday, July 14, 2022

LAS VEGAS, July 14, 2022 /PRNewswire/ --848 Global, endorsed by legendary music mogul Suge Knight, announced an exclusive licensing agreementwith Arisha Diversified for the immediate release of a complete line of Project 848 brand culture-related merchandise that includes Delta 8 THC products, CBD elixirs and topicals, glassware, apparel, terpenes and other accessories.

Key Points: 
  • LAS VEGAS, July 14, 2022 /PRNewswire/ --848 Global, endorsed by legendary music mogul Suge Knight, announced an exclusive licensing agreementwith Arisha Diversified for the immediate release of a complete line of Project 848 brand culture-related merchandise that includes Delta 8 THC products, CBD elixirs and topicals, glassware, apparel, terpenes and other accessories.
  • Arisha Diversifiedco-founder Sadie-Sha Turner extols, "Retailers act fast when an OG culture icon such as Suge Knight endorses a line of culture-relevant products to the masses," whileco-founder Ariel Millerdeclares, "We have seen large pockets of interest already occurring across the country, just based on the rumor of Suge Knight's 848 line."
  • A percentage of every sale from Project 848 products will further Suge's philanthropic measures tobenefit residents of Compton, California, where he was raised.
  • With Suge Knight's endorsement, Arisha Diversified's Project 848 launch is sure to gain momentum as this quality line of products improves the lives of both customers and residents in Compton's underserved community.

Chronic Renal/Kidney Transplant Rejection Market and Epidemiology Report 2022-2032 With 7 Major Market Analysis - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 28, 2022

The "Chronic Renal/Kidney Transplant Rejection - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Chronic Renal/Kidney Transplant Rejection - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering.
  • This "Chronic Renal/Kidney Transplant Rejection- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Renal/Kidney Transplant Rejection, historical and forecasted epidemiology as well as the Chronic Renal/Kidney Transplant Rejection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
  • The report covers the descriptive overview of Chronic Renal/Kidney Transplant Rejection, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
    Additionally, an all-inclusive account of both the current and emerging therapies for Chronic Renal/Kidney Transplant Rejection are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
    A detailed review of Chronic Renal/Kidney Transplant Rejection market; historical and forecasted is included in the report, covering drug outreach in the 7MM
    The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Chronic Renal/Kidney Transplant Rejection market
    In the coming years, Chronic Renal/Kidney Transplant Rejection market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
    The companies and academics are working to assess challenges and seek opportunities that could influence Chronic Renal/Kidney Transplant Rejection R&D.
  • The therapies under development are focused on novel approaches to treat/improve the disease condition
    Major players are involved in developing therapies for Chronic Renal/Kidney Transplant Rejection.

Chronic Cough Market Insights, Epidemiology and Market Forecast Report, 2019-2022 & 2032 - ResearchAndMarkets.com

Retrieved on: 
Monday, June 20, 2022

The "Chronic Cough - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Chronic Cough - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering.
  • This "Chronic Cough- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Cough, historical and forecasted epidemiology as well as the Chronic Cough market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
  • The Chronic Cough market report gives a thorough understanding of the Chronic Cough by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.
  • The Chronic Cough epidemiology division provide insights about historical and current Chronic Cough patient pool and forecasted trend for every seven major countries.

Annals of Family Medicine: Mayo Clinic research identifies health care access challenges of rural patients

Retrieved on: 
Tuesday, May 24, 2022

ANN ARBOR, Mich., May 24, 2022 /PRNewswire/ -- Rural residents face immense challenges to accessing health care services for chronic health conditions such as diabetes and cancer, which are associated with higher rates of disease-attributable deaths. Authors from the Mayo Clinic and the University of Louisville School of Medicine in Kentucky have just published a paper in Annals of Family Medicine that aggregates findings from 62 different studies to find commonalities in the health care experiences of patients with chronic conditions in U.S. rural settings.

Key Points: 
  • Authors from the Mayo Clinic and the University of Louisville School of Medicine in Kentucky have just published a paper in Annals of Family Medicine that aggregates findings from 62 different studies to find commonalities in the health care experiences of patients with chronic conditions in U.S. rural settings.
  • Their paper is titled, " Rural Patient Experiences of Accessing Care for Chronic Conditions: A Systematic Review and Thematic Synthesis of Qualitative Studies. "
  • The researchers found that important cultural, structural and individual factors influence the rural patient experience of health care access and utilization, including:
    Golembiewski et al believe their findings can inform policies and programs that may improve access to care through culturally-appropriate interventions.
  • "Improving access to health care in rural communities is a national imperative," the authors assert, adding that future research should explore the role of telehealth and other remote technologies to address patient access challenges and to collect patient care data.

Global Wound Care Market Size, Share & Trends Analysis Report 2022-2030: Stringent Manufacturing Policies Restraining Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 28, 2022

The "Wound Care Market Size, Share & Trends Analysis by Product (Surgical, Traditional), by Application (Chronic, Acute Wounds), by End-use (Hospitals, Clinics), by Active Wound Care, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Wound Care Market Size, Share & Trends Analysis by Product (Surgical, Traditional), by Application (Chronic, Acute Wounds), by End-use (Hospitals, Clinics), by Active Wound Care, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global wound care market size is anticipated to reach USD 29.57 billion by 2030, registering a CAGR of 4.12% during the forecast period.
  • Increasing number of surgical cases, rapidly aging population, as well as rising number of diabetic patients, are among the major factors driving the market growth.
  • Elder people are more susceptible to wounds, and thus, an increasing number of geriatric population is anticipated to propel the market growth.

Chronic' Founder, Known as Shahh, Shares His Journey To Becoming a Full-time Gaming Content Creator

Retrieved on: 
Monday, April 18, 2022

Their work has been seen on many platforms and they're followed by a huge community that supports their content.

Key Points: 
  • Their work has been seen on many platforms and they're followed by a huge community that supports their content.
  • Long before Chronic was a reality, Shah started his journey as a college dropout at the age of 18.
  • He then discovered the developing audience for gaming and recognized YouTube as a platform where he could decorate and escalate his skill.
  • His role as a digital content creator and enthusiast has guided him to play an important role in numerous digital niches.